Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
367-05-006 ISMRM Abstract

QSM Reveals Region-Specific Remyelination Patterns linked to Multiple Sclerosis Disease Progression

Primary: Neuro - Multiple Sclerosis
Secondary: Neuro - Neuroinflammation
367-05-006 · Neuroinflammation: Myelin and Iron · Monday, 11 May, 4:10 PM–5:05 PM · Digital Posters Row H
Keywords: Multiple Sclerosis Quantitative Susceptibility Mapping (QSM) Disease progression Remyelination Lesion Location
Accepted
Noa Bar Zohar1,2,3, Dimitrios G Gkotsoulias 1,2,3, Alessandro Cagol1,2,3,4, Mario Ocampo-Pineda1,2,3, Po-Jui Lu1,2,3, Tommaso Sirito1,5, Xinjie Chen1,2,3,6,7, Matthias Weigel1,2,3,8, Sven Cichon9,10,11, Jens Kuhle2,3, Ludwig Kappos2,3, Cristina Granziera1,2,3
1Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine, University Hospital Basel and University of Basel, Basel, Switzerland
2Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Switzerland
3Department of Neurology, University Hospital Basel and University of Basel, Basel, Switzerland., Switzerland
4Department of Health Sciences, University of Genova, Genova, Italy
5Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), Clinical Neurology, University of Genoa, Genoa, Italy
6Department of Pediatric Neurology and Developmental Medicine, University Children’s Hospital Basel (UKBB), Switzerland
7Donders Centre for Cognitive Neuroimaging, Radboud University, Nijmegen, Netherlands
8University Hospital Basel, Basel, Switzerland
9Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich, Jülich, Germany
10Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland, Switzerland
11Department of Biomedicine, University of Basel, Basel, Switzerland, Switzerland
Presenting Author: Dimitrios G Gkotsoulias

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Lubetzki, C., Zalc, B., Williams, A., Stadelmann, C. & Stankoff, B. Remyelination in multiple sclerosis: from basic science to clinical translation. The Lancet Neurology 19, 678–688 (2020). 10.1016/S1474-4422(20)30140-X. [doi]
2. Patrikios, P. et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165–3172 (2006). 10.1093/brain/awl217. [doi]
3. Strijbis, E. M. M., Kooi, E.-J., van der Valk, P. & Geurts, J. J. G. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis. J Neuropathol Exp Neurol 76, 390–401 (2017). 10.1093/jnen/nlx023. [doi]
4. Rahmanzadeh, R. et al. A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis. Ann Neurol 92, 486–502 (2022). 10.1002/ana.26441. [doi]
5. Li, W., Wu, B. & Liu, C. Quantitative Susceptibility Mapping of Human Brain Reflects Spatial Variation in Tissue Composition. Neuroimage 55, 1645–1656 (2011). 10.1016/j.neuroimage.2010.11.088. [doi]
6. Liu, T., Xu, W., Spincemaille, P., Avestimehr, A. S. & Wang, Y. Accuracy of the Morphology Enabled Dipole Inversion (MEDI) Algorithm for Quantitative Susceptibility Mapping in MRI. IEEE Trans Med Imaging 31, 816–824 (2012). 10.1002/mrm.22816. [doi]
7. La Rosa, F. et al. Multiple sclerosis cortical and WM lesion segmentation at 3T MRI: a deep learning method based on FLAIR and MP2RAGE. Neuroimage Clin 27, 102335 (2020). 10.1016/j.nicl.2020.102335. [doi]
8. Fischl, B. FreeSurfer. Neuroimage 62, 774–781 (2012). 10.1016/j.neuroimage.2012.01.021. [doi]
9. Filippi, M. et al. Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines. Brain 142, 1858–1875 (2019). 10.1093/brain/awz144. [doi]
10. Bergner, C. G. et al. BCAS1-positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis. Brain 148, 908–920 (2024). 10.1093/brain/awae293. [doi]
11. Brown, J. W. L. et al. Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Ann Clin Transl Neurol 9, 1626–1642 (2022). 10.1002/acn3.51662. [doi]
12. Galloway, D. A., Gowing, E., Setayeshgar, S. & Kothary, R. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination. Glia 68, 859–877 (2020). 10.1002/glia.23711. [doi]
13. Tonietto, M. et al. Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration. Brain 146, 182–194 (2023). 10.1093/brain/awac334. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/367-05-006